CLINICAL_TRIALS
trial_result
· 2021-09-09
Clinical Trial Update: Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients
Summary
A completed clinical trial evaluating response to Enbrel and the impact of RF and anti-CCP in rheumatoid arthritis patients, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Arthritis, Rheumatoid | Status: COMPLETED | Results posted: 2021-09-09